Dissection of lymph node metastases in esophageal cancer

References

• Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann. Surg.232(6), 733–742 (2000).
   PubMed Web of Science ®Google Scholar
• Hosch SB, Stoecklein NH, Pichlmeier U et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J. Clin. Oncol.19(7), 1970–1975 (2001).
   PubMed Web of Science ®Google Scholar
• Sgourakis G, Gockel I, Radtke A et al. Minimally invasive versus open esophagectomy: meta-analysis of outcomes. Dig. Dis. Sci.55(11), 3031–3040 (2010).
   PubMedGoogle Scholar
• Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Prognostic significance of the number of lymph node metastases in esophageal cancer. J. Am. Coll. Surg.206(2), 239–246 (2008).
   PubMedGoogle Scholar
• Akiyama H, Masahiko T, Udagawa H, Kijiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann. Surg.220(3), 364–373 (1994).
   PubMedGoogle Scholar
• Tachibana M, Kinugasa S, Shibakita M. Surgical treatment of superficial esophageal cancer. Langenbecks Arch. Surg.391(4), 304–321 (2006).
   PubMed Web of Science ®Google Scholar
• Lerut T, Coosemans W, De Leyn P, Decker G, Deneffe G, Van Raemdonck D. Is there a role for radical esophagectomy? Eur. J. Cardiothorac. Surg.16(Suppl. 1), S44–S47 (1999).
   PubMedGoogle Scholar
• Bollschweiler E, Schröder W, Hölscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br. J. Surg.87(8), 1106–1110 (2000).
   PubMedGoogle Scholar
• Siewert JR, Stein HJ, Sendler A. Esophageal cancer: clinical management. In: Principles and Practice of Gastrointestinal Oncology. Kelsen DA (Ed.). Lippincott William & Williams, PA, USA (2001).
   Google Scholar
• Gockel I, Kneist W, Junginger TH. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. World J. Surg.30(2), 183–190 (2006).
   PubMedGoogle Scholar
• Rice TW. Superficial oesophageal carcinoma: is there a need for three-field lymphadenectomy? Lancet354(9181), 792–794 (1999).
   PubMedGoogle Scholar
• Lerut T, Nafteux P, Moons J et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann. Surg.240(6), 962–974 (2004).
   PubMedGoogle Scholar
• Schuhmacher C, Novotny A, Ott K, Feith M, Siewert JR. Lymphadenectomy with tumors of the upper gastrointestinal tract. Chirurg78(3), 203–216 (2007).
   PubMedGoogle Scholar
• Wittekind C, Oberschmid B. [Gastrointestinal tumors: new N classification of the UICC]. Chirurg81(2), 81(2) 95–98; 100–102 (2010).
   PubMedGoogle Scholar
• Seto Y, Fukuda T, Yamada K et al. Celiac lymph nodes: distant or regional for thoracic esophageal carcinoma? Dis. Esophagus21(8), 704–707 (2008).
   PubMedGoogle Scholar
• Siewert JR, Stein HJ, Böttcher K. Lymphadenectomy in tumors of the upper gastrointestinal tract. Chirurg67(9), 877–888 (1996).
   PubMedGoogle Scholar
• Siewert JR, Stein HJ. Lymph-node dissection in squamous cell esophageal cancer – who benefits? Langenbeck’s Arch. Surg.384(2), 141–148 (1999).
   PubMedGoogle Scholar
• Hennessy TP. Lymph node dissection. World J. Surg.18(3), 367–372 (1994).
   PubMed Web of Science ®Google Scholar
• Jamieson GG, Lamb PJ, Thompson SK. The role of lymphadenectomy in esophageal cancer. Ann. Surg.250(2), 206–209 (2009).
   PubMedGoogle Scholar
• Merendino KA, Dillard DH. The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann. Surg.142(3), 486–506 (1955).
   PubMed Web of Science ®Google Scholar
• Ott K, Lordick F, Molls M, Bartels H, Biemer E, Siewert JR. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical esophagus. Br. J. Surg.96(3), 258–66 (2009).
   PubMedGoogle Scholar
• Böttger T, Bumb P, Dutkowski P, Schlick T, Junginger T. Carcinoma of the hypopharynx and cervical esophagus: a surgical challenge. Eur. J. Surg.165(10), 940–946 (1999).
   PubMedGoogle Scholar
• Siewert JR, Hölscher AH, Becker K, Gössner W. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg58(1), 25–32 (1987).
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagus and oesophagogastric junction. Br. J. Surg.85(11), 1457–1459 (1998).
   PubMed Web of Science ®Google Scholar
• Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann. Surg.232(3), 353–361 (2000).
   PubMed Web of Science ®Google Scholar
• Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J. Natl Cancer Inst.100(16), 1184–1187 (2008).
   PubMed Web of Science ®Google Scholar
• Feith M, Stein HJ, Siewert JR. Pattern of lymphatic spread of Barrett’s cancer. World J Surg.27(9), 1052–1057 (2003).
   PubMedGoogle Scholar
• Tachimori Y, Kato H, Watanabe H, Sasako M, Kinoshita T, Maruyama K. Difference between carcinoma of the lower esophagus and the cardia. World J. Surg.20(4), 507–511 (1996).
   PubMedGoogle Scholar
• Nigro JJ, Hagen JA, DeMeester TR et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J. Thorac. Cardiovasc. Surg.117(1), 16–25 (1999).
   PubMed Web of Science ®Google Scholar
• Dresner SM, Lamb PJ, Bennett MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery129(1), 103–109 (2001).
   PubMed Web of Science ®Google Scholar
• Mönig SP, Baldus SE, Zirbes TK et al. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. Hepatogastroenterology49(44), 419–422 (2002).
   PubMedGoogle Scholar
• Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer. Ann. Surg. Oncol.9(8), 807–811 (2002).
   PubMedGoogle Scholar
• Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann. Surg.236(2), 177–183 (2002).
   PubMed Web of Science ®Google Scholar
• van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and gastro-esophageal junction. Eur. J. Cardiothorac. Surg.15(6), 769–773 (1999).
   PubMedGoogle Scholar
• Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early esophageal cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology118(4), 670–677 (2000).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Haringsma J. Diagnostic and therapeutic endoscopy. J. Surg. Oncol.92(3), 203–209 (2005).
   PubMedGoogle Scholar
• van den Boogert J, van Hillegersberg R, Siersema PD, de Bruin RW, Tilanus HW. Endoscopic ablation therapy for Barrett’s esophagus with high-grade dysplasia: a review. Am. J. Gastroenterol.94(5), 1153–1160 (1999).
   PubMedGoogle Scholar
• May A, Gossner L, Pech O et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy34(8), 604–610 (2002).
   PubMed Web of Science ®Google Scholar
• Gossner L, Stolte M, Sroka R et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology114(3), 448–455 (1998).
   PubMed Web of Science ®Google Scholar
• Cense HA, van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract. Res. Clin. Gastroenterol.20(5), 893–906 (2006).
   PubMed Web of Science ®Google Scholar
• Manner H, May A, Pech O et al. Early Barrett’s carcinoma with ‘low-risk’ submucosal invasion: long-term results of endoscopic resection with a curative intent. Am. J. Gastroenterol.103(10), 2589–2597 (2008).
   PubMed Web of Science ®Google Scholar
• Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest. Endosc.60(5), 703–710 (2004).
   PubMed Web of Science ®Google Scholar
• Westerterp M, Koppert LB, Buskens CJ et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch.446(5), 497–504 (2005).
   PubMed Web of Science ®Google Scholar
• Gockel I, Sgourakis G, Lyros O et al. Risk for lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev. Gastroenterol. Hepatol. (2011) (In Press).
   PubMedGoogle Scholar
• Rizk NP, Ishwaran H, Rice TW et al. Optimum lymphadenectomy for esophageal cancer. Ann. Surg.251(1), 46–50 (2010).
   PubMed Web of Science ®Google Scholar
• Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer – pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann. Surg.242(4), 566–573 (2005).
   PubMed Web of Science ®Google Scholar
• Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann. Surg.246(3), 363–372 (2007).
   PubMedGoogle Scholar
• Hulscher JB, van Sandick JW, de Boer AG et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N. Engl J Med.347(21), 1662–1669 (2002).
   PubMed Web of Science ®Google Scholar
• Omloo JM, Lagarde SM, Hulscher JB et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five year survival of a randomised clinical trial. Ann. Surg.246(6), 992–1000 (2007).
   PubMed Web of Science ®Google Scholar
• Law S. Optimal surgical approach for esophagectomy: the debate still goes on? Ann. Thorac. Cardiovasc. Surg.15(5), 277–279 (2009).
   PubMedGoogle Scholar
• Peyre CG, Hagen JA, DeMeester SR et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann. Surg.248(6), 979–985 (2008).
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med.355(1), 11–20 (2006).
   PubMed Web of Science ®Google Scholar
• Takubo K, Aida J, Sawabe M et al. Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint. Histopathology51(6), 733–742 (2007)
   PubMed Web of Science ®Google Scholar
• Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis. Esophagus13(2), 125–129 (2000).
   PubMed Web of Science ®Google Scholar
• Eguchi T, Nakanishi Y, Shimoda T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod. Pathol.19(3), 475–480 (2006).
   PubMed Web of Science ®Google Scholar
• Matsubara T, Ueda M, Abe T, Akimori T, Kokudo N, Takahashi T. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br. J. Surg.86(5), 669–673 (1999).
   PubMed Web of Science ®Google Scholar
• Bollschweiler E, Baldus SE, Schröder W et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy38(2), 149–156 (2006).
   PubMed Web of Science ®Google Scholar
• Triboulet JP, Mariette C, Chevalier D, Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus. Analysis of 209 cases. Arch. Surg.136(10), 1164–1170 (2001).
   PubMedGoogle Scholar
• Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am. J. Surg.185(6), 538–543 (2003).
   PubMed Web of Science ®Google Scholar
• Fiorica F, Di Bona D, Schepis F et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut.53(7), 925–930 (2004).
   PubMed Web of Science ®Google Scholar
• Malthaner RA, Wong RK, Rumble RB, Zuraw L; members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med.24(2), 35–51 (2004).
   Google Scholar
• Stuschke M, Sarbia M. Neoadjuvante radiochemotherapie und responseprädiktion. Onkologe10, 1179–1190 (2004).
   Google Scholar
• Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery137(2), 172–177 (2005).
   PubMed Web of Science ®Google Scholar
• Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; for the Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol.8(3), 226–234 (2007).
   PubMed Web of Science ®Google Scholar
• Doki Y, Ishikawa O, Takachi K et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J. Surg.29(6), 700–707 (2005).
   PubMedGoogle Scholar
• Law S, Wong J. Current management of esophageal cancer. J. Gastrointest. Surg.9(2), 291–310 (2005).
   PubMedGoogle Scholar
• Hsu CP, Hsu NY, Shai SE, Hsia JY, Chen CY. Pre-tracheal lymph node metastasis in squamous cell carcinoma of the thoracic esophagus. Eur J. Surg. Oncol.31(7), 749–754 (2005).
   PubMedGoogle Scholar
• Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field lymphadenectomy. Ann. Surg.239(4), 483–490 (2004).
   PubMedGoogle Scholar
• Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am. J. Surg.175(1), 47–51 (1998).
   PubMedGoogle Scholar
• Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K, Muto T. Clinical implications of cervical lymph node metastasis patterns in thoracic esophageal cancer. Ann. Surg.220(6), 775–781 (1994).
   PubMedGoogle Scholar
• Fang WT, Chen WH. Current trends in extended lymph node dissection for esophageal carcinoma. Asian Cardiovasc. Thorac. Ann.17(2), 208–213 (2009).
   PubMedGoogle Scholar
• Tabira Y, Okuma T, Sakaguchi T, Kuhara H, Teshima K, Kawasuji M. Three-field dissection or two-field dissection? A proposal of new algorithm for lymphadenectomy. Hepatogastroenterology51(58), 1015–1020 (2004).
   PubMedGoogle Scholar